Magnesium sulfate added to lidocaine for trigger point injections in myofascial pain
Official title: Evaluation of the Effect of Adding Magnesium Sulfate to Lidocaine in the Treatment of Myofascial Pain Dysfunction Syndrome Using Surface Electromyography (sEMG).(Randomized Clinical Trial)
Run by Cairo University · NCT07390851 · Data updated 2026-11-12
This study will see if adding magnesium sulfate to lidocaine injections helps reduce pain and relax muscles in adults with myofascial pain dysfunction syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 28 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Giza, Giza Governorate) |
| Status | Recruiting |
| Started | November 26, 2025 |
| Main results expected | November 26, 2026 |
| Study ends | November 26, 2026 |
| Registry record updated | February 5, 2026 |
| Trial ID | NCT07390851 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 with a clinical diagnosis of MPDS, active accessible trigger points, pain for at least 3 months, baseline VAS ≥ 4, and no trigger point injection in the affected area within the prior 3 months are ideal candidates.
✕Probably not a fit
Patients with central pain syndromes (such as fibromyalgia), cancer-related pain, allergies to lidocaine or magnesium, bleeding disorders, local infections, or recent surgery/trauma in the area are unlikely to benefit or may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In a randomized trial, adults with clinically diagnosed Myofascial Pain Dysfunction Syndrome will be assigned to receive trigger point injections of either lidocaine 2% alone or lidocaine 2% combined with magnesium sulfate 10%. Injections will be given into identified active myofascial trigger points and pain during and after injection will be measured using a Visual Analog Scale (VAS). Muscle activity will be recorded with surface electromyography (sEMG) at specified time points during rest and contraction to compare muscle relaxation between groups. The study compares changes in pain scores and sEMG readings to determine whether magnesium sulfate provides additional analgesic or muscle-relaxing effects.
Why it matters
Potential benefit: If successful, the combination could provide greater pain relief and improved muscle relaxation after trigger point injections for patients with MPDS.
How similar studies have gone: Magnesium sulfate has shown mixed but sometimes promising results as an adjuvant to local anesthetics in other pain settings, but its specific use in trigger point injections for MPDS is limited and not well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age between 18 and 70 years. 2. Clinical diagnosis of Myofascial Pain Dysfunction Syndrome (MPDS). 3. Presence of active myofascial trigger points in accessible muscles (e.g., masseter, temporalis, upper trapezius). 4. Pain duration ≥ 3 months. 5. Pain intensity ≥ 4 on the Visual Analog Scale (VAS). 6. Noprior trigger point injection in the affected area within the past 3 months. 7. Ability and willingness to provide informed consent. 8. Compliance with study visits and procedures Exclusion Criteria: 1. Known allergy or hypersensitivity to Lidocaine, Magnesium Sulfate, or related agents. 2. Current use of anticoagulants or history of bleeding disorders. 3. Systemic or local infection at or near the injection site. 4. History of fibromyalgia, central pain syndromes, or cancer-related pain. 5. Major psychiatric illnesses (e.g., schizophrenia, severe depression). 6. Recent surgery or trauma to the head, neck, or upper back (\<6 months). 7. Use of analgesics (NSAIDs, opioids) within 5 days before intervention. 8. Severe systemic diseases:- Uncontrolled diabetes mellitus- Liver or kidney failure- Severe cardiovascular conditions.
Where it's running
-
Faculty of oral and dental medicine, cairo university
Giza, Giza Governorate, Egypt Recruiting
Study contacts
- Principal investigator: Maii E Abdelazeem, Bsc — Faculty of Oral & Dental Medicine, Cairo University
- Study coordinator: Maii E Abdelazeem, BSc
- Email: Maii.emad@dentistry.cu.edu.eg
- Phone: +20 1013988933
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Buffered lidocaine for myofascial pain: a comparison with lidocaine alone
This study tests whether adding sodium bicarbonate to lidocaine can improve pain relief for people with myofascial pain syndrome.
-
PRP, PRP with Betamethasone, or Betamethasone Injection for Upper Trapezius Myofascial Pain
Three injectable treatments are tested to see which best reduces pain and helps function for people with upper trapezius myofascial pain.
-
Focused Shockwave Therapy for neck and shoulder pain
A 60-person study tests whether focused shockwave therapy can reduce pain and improve function in adults with chronic neck and shoulder myofascial pain compared with a home exercise program.
-
Tele-rehabilitation for rhomboid trigger points in myofascial pain syndrome
This trial tests whether tele-rehabilitation with self-myofascial release and exercise can reduce neck pain and improve function in adults with rhomboid trigger points.
-
Three treatment options for myofascial back pain
This trial will test whether dry needling, shock wave therapy (ESWT), or pulsed radiofrequency (PRF) reduces pain and improves function in adults 18–65 with chronic myofascial back pain.
-
Reflex therapy and dry needling for jaw muscle and joint pain
This trial will try adding dry needling to standard rehabilitation to see if adults with functional temporomandibular (jaw) pain get less pain, better jaw movement, and improved quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.